Glaukos Corp. Stock, NYSE:GKOS
229 Avenida Fabricante, 229 Avenida Fabricante, San Clemente, California 92672
United States of America
Number of Employees: 600
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.